BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28637783)

  • 1. Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a.
    Cheng HS; Besla R; Li A; Chen Z; Shikatani EA; Nazari-Jahantigh M; Hammoutène A; Nguyen MA; Geoffrion M; Cai L; Khyzha N; Li T; MacParland SA; Husain M; Cybulsky MI; Boulanger CM; Temel RE; Schober A; Rayner KJ; Robbins CS; Fish JE
    Circ Res; 2017 Aug; 121(4):354-367. PubMed ID: 28637783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis.
    Del Monte A; Arroyo AB; Andrés-Manzano MJ; García-Barberá N; Caleprico MS; Vicente V; Roldán V; González-Conejero R; Martínez C; Andrés V
    PLoS One; 2018; 13(6):e0198932. PubMed ID: 29902229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.
    Li K; Ching D; Luk FS; Raffai RL
    Circ Res; 2015 Jun; 117(1):e1-e11. PubMed ID: 25904598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
    Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, type 1/low-density lipoprotein receptor double knockout mice.
    Fuller M; Dadoo O; Serkis V; Abutouk D; MacDonald M; Dhingani N; Macri J; Igdoura SA; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2394-403. PubMed ID: 25212235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy.
    Pankratz F; Hohnloser C; Bemtgen X; Jaenich C; Kreuzaler S; Hoefer I; Pasterkamp G; Mastroianni J; Zeiser R; Smolka C; Schneider L; Martin J; Juschkat M; Helbing T; Moser M; Bode C; Grundmann S
    Circ Res; 2018 Feb; 122(3):417-432. PubMed ID: 29208678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation.
    Cremer S; Michalik KM; Fischer A; Pfisterer L; Jaé N; Winter C; Boon RA; Muhly-Reinholz M; John D; Uchida S; Weber C; Poller W; Günther S; Braun T; Li DY; Maegdefessel L; Perisic Matic L; Hedin U; Soehnlein O; Zeiher A; Dimmeler S
    Circulation; 2019 Mar; 139(10):1320-1334. PubMed ID: 30586743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA mediation of endothelial inflammatory response to smooth muscle cells and its inhibition by atheroprotective shear stress.
    Chen LJ; Chuang L; Huang YH; Zhou J; Lim SH; Lee CI; Lin WW; Lin TE; Wang WL; Chen L; Chien S; Chiu JJ
    Circ Res; 2015 Mar; 116(7):1157-69. PubMed ID: 25623956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages.
    Nguyen MA; Hoang HD; Rasheed A; Duchez AC; Wyatt H; Cottee ML; Graber TE; Susser L; Robichaud S; Berber İ; Geoffrion M; Ouimet M; Kazan H; Maegdefessel L; Mulvihill EE; Alain T; Rayner KJ
    Circ Res; 2022 Jun; 131(1):42-58. PubMed ID: 35611698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice.
    Hasu M; Thabet M; Tam N; Whitman SC
    Can J Physiol Pharmacol; 2011 Oct; 89(10):737-42. PubMed ID: 21895526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration.
    Nguyen MA; Karunakaran D; Geoffrion M; Cheng HS; Tandoc K; Perisic Matic L; Hedin U; Maegdefessel L; Fish JE; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):49-63. PubMed ID: 28882869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
    Loyer X; Potteaux S; Vion AC; Guérin CL; Boulkroun S; Rautou PE; Ramkhelawon B; Esposito B; Dalloz M; Paul JL; Julia P; Maccario J; Boulanger CM; Mallat Z; Tedgui A
    Circ Res; 2014 Jan; 114(3):434-43. PubMed ID: 24255059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis.
    Patel KM; Strong A; Tohyama J; Jin X; Morales CR; Billheimer J; Millar J; Kruth H; Rader DJ
    Circ Res; 2015 Feb; 116(5):789-96. PubMed ID: 25593281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-146a-3p/HDAC1/KLF5/IKBα signal axis modulates plaque formation of atherosclerosis mice.
    Liu H; Wang H; Ma J; Qiao Z; Zhang L; Ge G
    Life Sci; 2021 Nov; 284():119615. PubMed ID: 34004248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-146a-5p association with the cardiometabolic disease risk factor TMAO.
    Coffey AR; Kanke M; Smallwood TL; Albright J; Pitman W; Gharaibeh RZ; Hua K; Gertz E; Biddinger SB; Temel RE; Pomp D; Sethupathy P; Bennett BJ
    Physiol Genomics; 2019 Feb; 51(2):59-71. PubMed ID: 30633643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
    Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
    PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.